Reduced Lp(a) with PCSK9 inhibitors in individuals with high Lp(a) at baseline contributes to CV risk reduction - PACE-CME

Reduced Lpa with PCSK inhibitors in individuals with high Lpa at baseline contributes to CV risk reduction

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Moving from ignorance on the complexity of HDL to novel therapeutic opportunities
Moving from ignorance on the complexity of HDL to novel therapeutic opportunities
EAS 2019
Moving from ignorance on the complexity of HDL to novel therapeutic opportunities
Growing importance of lowering remnants, also in light of the obesity epidemic
Growing importance of lowering remnants, also in light of the obesity epidemic
EAS 2019
Growing importance of lowering remnants, also in light of the obesity epidemic
Effect of IL-1β inhibition on lung cancer sheds new light on the role of inflammation
Effect of IL-1β inhibition on lung cancer sheds new light on the role of inflammation
EAS 2019
Effect of IL-1β inhibition on lung cancer sheds new light on the role of inflammation
- Paul Ridker, MD
More intelligent intervention through more strategic use of CV biomarkers
More intelligent intervention through more strategic use of CV biomarkers
EAS 2019
More intelligent intervention through more strategic use of CV biomarkers